<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03740347</url>
  </required_header>
  <id_info>
    <org_study_id>APHP180230</org_study_id>
    <secondary_id>2018-A02317-48</secondary_id>
    <nct_id>NCT03740347</nct_id>
  </id_info>
  <brief_title>Chronic Non-inflammatory Pains in Rheumatopediatrics</brief_title>
  <acronym>RHUMEDOL</acronym>
  <official_title>Chronic Non-inflammatory Pains in Rheumatopediatrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the frequency of chronic pain in adolescent with
      juvenile idiopathic arthritis, especially when the disease is inactive or with minimal
      activity.

      Secondary objectives are, first to determine intensity of pain and its repercussion in daily
      life and second to determine risk factor of chronic pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Juvenile idiopathic arthritis is the most frequent pathology in paediatric rheumatology
      clinic. Pain is an important symptom in paediatric rheumatology. It is actually poorly
      studied and is not evaluate in disease activity score like the Juvenile Arthritis Disease
      Activity Score (JADAS). It is source of handicap, social and psychological distress and
      greatly contribute to poor quality of life. Chronic pain is frequently multifactorial, even
      in inflammatory disease. In adult population, rheumatologists have shown an association
      between inflammatory disease like spondylarthritis or rheumatology polyarthritis and
      fibromyalgia.

      There is no specific data on chronic pain in juvenile idiopathic arthritis. Pain is mostly
      evaluated by the Visual Analogue Scale (VAS) with no evaluation of pain repercussion on daily
      life or its chronicity. This study's primary objective is to determine the frequency of
      chronic pain and its relationship with disease activity. Secondaries objectives are to
      determine repercussion of pain in daily life, and risk factor of chronic pain.

      To responded to this objective, we will conduct a transversal study in a paediatric
      rheumatology refence centre in Necker-Enfants malades Hospital. We will include all patients
      between 12 and 18 years old followed in our centre for any type of juvenile idiopathic
      arthritis.

      Patients will be evaluated as usual by their paediatrics rheumatologist during a follow-up
      consultation or hospitalisation with the used of the clinical JADAS. Patient accepting to
      participate the study will be given a paper questionnaire evaluating chronic pain, its
      repercussion, anxiety (by the used of the Revised Children's Manifest Anxiety Scale (RCMAS
      score)), depression (by the used of the Children's Depression Inventory (CDI score)),
      Sleepiness (by the used of the Pediatric Daytime Sleepiness Scale (PDSS score)) and quality
      of life (by the used of the measurement model for the Pediatric Quality of Life inventory
      (PedQL score)).
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Withdrawn study
  </why_stopped>
  <start_date type="Anticipated">December 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of chronic pain and its relationship with disease activity</measure>
    <time_frame>Day 0</time_frame>
    <description>Chronic pain will be defined by the presence of recurrent or permanent moderate pain (Visual Analogue Scale (VAS) &gt; 3 / 10), present more than 3 days a week.
Disease activity will be evaluated by the clinical Juvenile Arthritis Disease Activity Score (JADAS) and the definition of three groups: inactive disease, minimal disease activity and active disease.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chronic pain and disease repercussions</measure>
    <time_frame>Day 0</time_frame>
    <description>Chronic pain and disease repercussion will be assessed by a paper questionnaire evaluation repercussion on scholarship, sports, sleep and social interaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repercussions of pain on patient anxiety</measure>
    <time_frame>Day 0</time_frame>
    <description>Anxiety symptoms will be assessed with the Revised Children's Manifest Anxiety Scale (RCMAS) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repercussions of pain on depression symptoms</measure>
    <time_frame>Day 0</time_frame>
    <description>Depression symptoms will be assessed with the Children's Depression Inventory (CDI) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repercussions of pain on quality of life</measure>
    <time_frame>Day 0</time_frame>
    <description>Anxiety symptoms will be assessed with the Pediatric Quality of Life inventory (PedQL) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repercussions of pain on patient daytime sleepiness</measure>
    <time_frame>Day 0</time_frame>
    <description>Anxiety symptoms will be assessed with the Pediatric Daytime Sleepiness Scale (PDSS score)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Juvenile Idiopathic Arthritis</condition>
  <arm_group>
    <arm_group_label>Juvenile idiopathic arthritis and chronic pain</arm_group_label>
    <description>Patients followed for juvenile idiopathic arthritis and chronic pain in Necker Hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Response to questionnaires evaluating chronic pain and its repercussion :
anxiety questionnaire (Revised Children's Manifest Anxiety Scale),
depression questionnaire (Children's Depression Inventory score),
sleepiness questionnaire (Pediatric Daytime Sleepiness Scale),
quality of life questionnaire (Pediatric Quality of Life inventory score).</description>
    <arm_group_label>Juvenile idiopathic arthritis and chronic pain</arm_group_label>
    <other_name>Evaluation of the chronic pain repercussion in juvenile idiopathic arthritis</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 12 years of age followed for juvenile idiopathic arthritis in the reference
        center at Necker-Enfants malades Hospital (RAISE)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Child from 12 to 17 years old

          -  Follow-up to Necker Hospital by a rheumatologist at the reference center for juvenile
             idiopathic arthritis (RAISE), regardless of the form

          -  Not opposed to participating in the study

        Exclusion Criteria:

        No exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxime Goirand, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AP-HP, Functional Unit of &quot;Pain and Palliative Medicine&quot; - Necker-Enfants malades Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Functional Unit of &quot;Pain and Palliative Medicine&quot;- Necker-Enfants malades Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007 Mar 3;369(9563):767-778. doi: 10.1016/S0140-6736(07)60363-8. Review.</citation>
    <PMID>17336654</PMID>
  </reference>
  <reference>
    <citation>Consolaro A, Ravelli A. Paediatric rheumatology: Juvenile idiopathic arthritis--are biologic agents effective for pain? Nat Rev Rheumatol. 2013 Aug;9(8):447-8. doi: 10.1038/nrrheum.2013.108. Epub 2013 Jul 2.</citation>
    <PMID>23820859</PMID>
  </reference>
  <reference>
    <citation>Tupper SM, Rosenberg AM, Pahwa P, Stinson JN. Pain intensity variability and its relationship with quality of life in youths with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 Apr;65(4):563-70. doi: 10.1002/acr.21850.</citation>
    <PMID>22972759</PMID>
  </reference>
  <reference>
    <citation>Lalloo C, Stinson JN. Assessment and treatment of pain in children and adolescents. Best Pract Res Clin Rheumatol. 2014 Apr;28(2):315-30. doi: 10.1016/j.berh.2014.05.003. Review.</citation>
    <PMID>24974065</PMID>
  </reference>
  <reference>
    <citation>Duffield SJ, Miller N, Zhao S, Goodson NJ. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2018 Aug 1;57(8):1453-1460. doi: 10.1093/rheumatology/key112. Review.</citation>
    <PMID>29788461</PMID>
  </reference>
  <reference>
    <citation>McErlane F, Beresford MW, Baildam EM, Chieng SE, Davidson JE, Foster HE, Gardner-Medwin J, Lunt M, Wedderburn LR, Thomson W, Hyrich KL; Childhood Arthritis Prospective Study (CAPS). Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis. 2013 Dec;72(12):1983-8. doi: 10.1136/annrheumdis-2012-202031. Epub 2012 Dec 20.</citation>
    <PMID>23256951</PMID>
  </reference>
  <reference>
    <citation>Reynolds CR. Concurrent validity of &quot;What I think and feel:&quot; the Revised Children's Manifest Anxiety Scale. J Consult Clin Psychol. 1980 Dec;48(6):774-5.</citation>
    <PMID>7440835</PMID>
  </reference>
  <reference>
    <citation>Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21(4):995-8.</citation>
    <PMID>4089116</PMID>
  </reference>
  <reference>
    <citation>Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999 Feb;37(2):126-39.</citation>
    <PMID>10024117</PMID>
  </reference>
  <reference>
    <citation>Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B. The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep. 2003 Jun 15;26(4):455-8.</citation>
    <PMID>12841372</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>November 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Juvenile idiopathic arthritis</keyword>
  <keyword>chronic pain</keyword>
  <keyword>anxiety</keyword>
  <keyword>depression</keyword>
  <keyword>sleepiness</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

